Module 30

General Properties
Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module.
Num gene sets:	4
Num genes:	22 (see 1349 additional genes for this module)
Num experiments:	39 (26 induced, 13 repressed)
Parent module:	71
Children modules:	0

Gene sets
Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates.
organic acid transporter activity
carboxylic acid transport
monocarboxylic acid transporter activity
monocarboxylic acid transport

Enriched clinical annotations
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched.
Clinical annotation	Category	P-value	Hits	Hits(%)	Module hits in category	Arrays in annotation	Arrays
Breast cancer or cell line (General compendium)	General compendium	5.8e-05	9	37.5	24	159	1946
Female hormonal cancer cell line (Breast cancer)	Breast cancer	8.8e-05	5	71.4	7	15	152
Breast tissue, cancer or cell line (General compendium)	General compendium	0.0001	9	37.5	24	178	1946
Female hormonal cancer or cell line (General compendium)	General compendium	0.0001	9	37.5	24	180	1946
Breast cancer cell line (Breast cancer)	Breast cancer	0.0001	5	71.4	7	17	152
Female hormonal tissue, cancer or cell line (General compendium)	General compendium	0.0003	9	37.5	24	203	1946

Enriched GO annotations
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column).
GO annotation	P-value	Hits	Hits(%)	Module genes	Genes in annotation	Genes
organic acid transporter activity	2.1e-38	19	86.3	22	42	4609
organic acid transport	8.3e-32	16	72.7	22	34	4609
carboxylic acid transporter activity	6.6e-27	14	63.6	22	32	4609
carboxylic acid transport	8.6e-25	13	59.0	22	30	4609
organic anion transporter activity	1.7e-17	9	40.9	22	19	4609
response to drug	4.0e-16	14	63.6	22	157	4609
porter activity	1.6e-15	10	45.4	22	45	4609
proton-dependent oligopeptide transporter activity	2.6e-15	9	40.9	22	30	4609
peptide transporter activity	3.6e-15	9	40.9	22	31	4609
symporter activity	3.6e-15	9	40.9	22	31	4609
monocarboxylic acid transport	6.3e-15	7	31.8	22	11	4609
monocarboxylic acid transporter activity	4.6e-13	6	27.2	22	9	4609
organic anion transport	2.5e-12	6	27.2	22	11	4609
response to chemical substance	5.4e-12	14	63.6	22	309	4609
ion transporter activity	9.9e-12	11	50	22	144	4609
small molecule transport	6.2e-11	10	45.4	22	123	4609
amino acid transport	1.0e-10	6	27.2	22	18	4609
membrane fraction	2.1e-09	12	54.5	22	306	4609
amino acid transporter activity	2.2e-08	5	22.7	22	20	4609
organic cation transporter activity	8.0e-08	4	18.1	22	10	4609
sodium ion transport	1.6e-07	5	22.7	22	29	4609
solute\:solute exchange	2.0e-07	5	22.7	22	30	4609
integral to plasma membrane	6.0e-07	13	59.0	22	616	4609
organic acid\:sodium symporter activity	9.3e-07	3	13.6	22	5	4609
permease activity	1.4e-06	5	22.7	22	44	4609
cation transporter activity	1.6e-06	5	22.7	22	45	4609
dicarboxylic acid transporter activity	1.8e-06	3	13.6	22	6	4609
solute\:sodium symporter activity	7.7e-06	3	13.6	22	9	4609
ATP-binding cassette (ABC) transporter activity	1.1e-05	4	18.1	22	31	4609
uptake permease activity	1.8e-05	4	18.1	22	35	4609
amine/polyamine transporter activity	4.1e-05	3	13.6	22	15	4609

Visual display

Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets.

You can also view the images within GeneXPress by loading the module gxp file file.

>4x